Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | São Paulo medical journal (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802022005021219 |
Resumo: | ABSTRACT BACKGROUND: Hesitation and refusal to take a second dose of the vaccine for coronavirus disease 19 (COVID-19) are prevalent. OBJECTIVES: We aimed to identify predictive factors for hesitation or refusal and describe groups with higher rates of vaccine hesitancy. DESIGN AND SETTING: A cross-sectional study in Assis City, Brazil. METHODS: The study included adults who passed the due date for taking the COVID-19 second dose vaccine. Participants were recruited in December 2021 using a mobile-based text message. Sociodemographic and clinical data and reasons for hesitance were collected. The outcome was the attitude towards completing the recommended second dose of the vaccine. Bivariate and multivariate Poisson analyses were performed to determine the adjusted predictors. RESULTS: Participants between 30–44 years of age had a 2.41 times higher prevalence of hesitation than those aged 18–29 years. In addition, people who had adverse events or previously had COVID-19 had 4.7 and 5.4 times higher prevalences of hesitation, respectively (P value < 0.05). CONCLUSION: We found a significant group of adults aged between 30–44 years who refused the second dose of the COVID-19 vaccine. Furthermore, those who reported adverse effects after the first dose and those who had COVID-19 previously were a significant group for refusal. |
id |
APM-1_430c473f15eafd3870b8735997d64abe |
---|---|
oai_identifier_str |
oai:scielo:S1516-31802022005021219 |
network_acronym_str |
APM-1 |
network_name_str |
São Paulo medical journal (Online) |
repository_id_str |
|
spelling |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of BrazilCOVID-19Vaccination hesitancyVaccinationVaccination refusalAnti-vaccination movementCoronavirus disease 19Immunization, activeAnti-vaccine groupsABSTRACT BACKGROUND: Hesitation and refusal to take a second dose of the vaccine for coronavirus disease 19 (COVID-19) are prevalent. OBJECTIVES: We aimed to identify predictive factors for hesitation or refusal and describe groups with higher rates of vaccine hesitancy. DESIGN AND SETTING: A cross-sectional study in Assis City, Brazil. METHODS: The study included adults who passed the due date for taking the COVID-19 second dose vaccine. Participants were recruited in December 2021 using a mobile-based text message. Sociodemographic and clinical data and reasons for hesitance were collected. The outcome was the attitude towards completing the recommended second dose of the vaccine. Bivariate and multivariate Poisson analyses were performed to determine the adjusted predictors. RESULTS: Participants between 30–44 years of age had a 2.41 times higher prevalence of hesitation than those aged 18–29 years. In addition, people who had adverse events or previously had COVID-19 had 4.7 and 5.4 times higher prevalences of hesitation, respectively (P value < 0.05). CONCLUSION: We found a significant group of adults aged between 30–44 years who refused the second dose of the COVID-19 vaccine. Furthermore, those who reported adverse effects after the first dose and those who had COVID-19 previously were a significant group for refusal.Associação Paulista de Medicina - APM2022-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802022005021219Sao Paulo Medical Journal n.ahead 2022reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APM10.1590/1516-3180.2022.0095.r1.06072022info:eu-repo/semantics/openAccessSartorão-Filho,Carlos IzaiasZoqui,Mariana CostaDuarte,Douglas OtomoRibeiro,Edy AlysonBisetto,Vinicius César QueirozCachoni,Lara Escobar GaviãoSartorão,Ana Luísa VarroneTerribile,Diogo CoutinhoMello,Beatriz Balsimelli deSartorão-Neto,Carlos IzaiasMello,Roberto deeng2022-08-24T00:00:00Zoai:scielo:S1516-31802022005021219Revistahttp://www.scielo.br/spmjhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2022-08-24T00:00São Paulo medical journal (Online) - Associação Paulista de Medicinafalse |
dc.title.none.fl_str_mv |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil |
title |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil |
spellingShingle |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil Sartorão-Filho,Carlos Izaias COVID-19 Vaccination hesitancy Vaccination Vaccination refusal Anti-vaccination movement Coronavirus disease 19 Immunization, active Anti-vaccine groups |
title_short |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil |
title_full |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil |
title_fullStr |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil |
title_full_unstemmed |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil |
title_sort |
Prediction and reasons for COVID-19 second dose vaccine hesitation: a cross-sectional study in a municipality of Brazil |
author |
Sartorão-Filho,Carlos Izaias |
author_facet |
Sartorão-Filho,Carlos Izaias Zoqui,Mariana Costa Duarte,Douglas Otomo Ribeiro,Edy Alyson Bisetto,Vinicius César Queiroz Cachoni,Lara Escobar Gavião Sartorão,Ana Luísa Varrone Terribile,Diogo Coutinho Mello,Beatriz Balsimelli de Sartorão-Neto,Carlos Izaias Mello,Roberto de |
author_role |
author |
author2 |
Zoqui,Mariana Costa Duarte,Douglas Otomo Ribeiro,Edy Alyson Bisetto,Vinicius César Queiroz Cachoni,Lara Escobar Gavião Sartorão,Ana Luísa Varrone Terribile,Diogo Coutinho Mello,Beatriz Balsimelli de Sartorão-Neto,Carlos Izaias Mello,Roberto de |
author2_role |
author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Sartorão-Filho,Carlos Izaias Zoqui,Mariana Costa Duarte,Douglas Otomo Ribeiro,Edy Alyson Bisetto,Vinicius César Queiroz Cachoni,Lara Escobar Gavião Sartorão,Ana Luísa Varrone Terribile,Diogo Coutinho Mello,Beatriz Balsimelli de Sartorão-Neto,Carlos Izaias Mello,Roberto de |
dc.subject.por.fl_str_mv |
COVID-19 Vaccination hesitancy Vaccination Vaccination refusal Anti-vaccination movement Coronavirus disease 19 Immunization, active Anti-vaccine groups |
topic |
COVID-19 Vaccination hesitancy Vaccination Vaccination refusal Anti-vaccination movement Coronavirus disease 19 Immunization, active Anti-vaccine groups |
description |
ABSTRACT BACKGROUND: Hesitation and refusal to take a second dose of the vaccine for coronavirus disease 19 (COVID-19) are prevalent. OBJECTIVES: We aimed to identify predictive factors for hesitation or refusal and describe groups with higher rates of vaccine hesitancy. DESIGN AND SETTING: A cross-sectional study in Assis City, Brazil. METHODS: The study included adults who passed the due date for taking the COVID-19 second dose vaccine. Participants were recruited in December 2021 using a mobile-based text message. Sociodemographic and clinical data and reasons for hesitance were collected. The outcome was the attitude towards completing the recommended second dose of the vaccine. Bivariate and multivariate Poisson analyses were performed to determine the adjusted predictors. RESULTS: Participants between 30–44 years of age had a 2.41 times higher prevalence of hesitation than those aged 18–29 years. In addition, people who had adverse events or previously had COVID-19 had 4.7 and 5.4 times higher prevalences of hesitation, respectively (P value < 0.05). CONCLUSION: We found a significant group of adults aged between 30–44 years who refused the second dose of the COVID-19 vaccine. Furthermore, those who reported adverse effects after the first dose and those who had COVID-19 previously were a significant group for refusal. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802022005021219 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802022005021219 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/1516-3180.2022.0095.r1.06072022 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Paulista de Medicina - APM |
publisher.none.fl_str_mv |
Associação Paulista de Medicina - APM |
dc.source.none.fl_str_mv |
Sao Paulo Medical Journal n.ahead 2022 reponame:São Paulo medical journal (Online) instname:Associação Paulista de Medicina instacron:APM |
instname_str |
Associação Paulista de Medicina |
instacron_str |
APM |
institution |
APM |
reponame_str |
São Paulo medical journal (Online) |
collection |
São Paulo medical journal (Online) |
repository.name.fl_str_mv |
São Paulo medical journal (Online) - Associação Paulista de Medicina |
repository.mail.fl_str_mv |
revistas@apm.org.br |
_version_ |
1754209269032419328 |